Abstract
Get full access to this article
View all access options for this article.
References
1.
Leonard BE
. Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance . Drugs 1992 ; 43 (suppl):3 –10 .
2.
Cooper GL
. The safety of fluoxetine—an update . Br J Psychiatry 1988 ; 153 (suppl):77 –86 .
3.
Boyer WF
,
Blumehardt CL
. The safety profile of paroxetine . J Clin Psychiatry 1992 ; 53 (suppl):61 –6 .
4.
Dilsaver SC
,
Greden JF
. Antidepressant withdrawal phenomena . Biol Psychiatry 1984 ; 19 : 237 –56 .
5.
Garner EM
,
Kelly MW
,
Thompson DF
. Tricyclic antidepressant withdrawal syndrome . Ann Pharmacother 1993 ; 27 : 1068 –72 .
6.
DeVane CL
. Pharmacokinetics of the newer antidepressants: clinical relevance . Am J Med 1994 ; 97 (suppl):6S –13S .
7.
Grimsley SR
,
Jann MW
. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors . Clin Pharm 1992 ; 11 : 930 –57 .
8.
Louie AK
,
Lannon RA
,
Ajari LJ
. Withdrawal reaction after sertraline discontinuation (letter) . Am J Psychiatry 1994 ; 151 : 450 –1 .
9.
Frost L
,
Lal S.
Shock-like sensations after discontinuation of SSRIs (letter) . Am J Psychiatry 1995 ; 152 : 810 .
10.
Gelenberg AJ
, ed. Postmarketing watch: paroxetine in the UK . Biol Ther Psychiatry 1993 ; 16 : 25 –8 .
11.
Barr LC
,
Goodman WK
,
Price LH
. Physical symptoms associated with paroxetine discontinuation (letter) . Am J Psychiatry 1994 ; 151 : 289 .
12.
Keuthen NJ
,
Cyr P
,
Ricciardi JA
,
Minichiello WE
,
Buttolph ML
,
Jenike MA
. Medication withdrawal symptoms in obsessive-compulsive disorder. Patients treated with paroxetine (letter) . J Clin Psychopharmacol 1994 ; 14 : 206 –7 .
13.
Pyke RE
. Paroxetine withdrawal syndrome (letter) . Am J Psychiatry 1995 ; 152 : 149 –50 .
14.
Phillips SD
. A possible paroxetine withdrawal syndrome (letter) . Am J Psychiatry 1995 ; 152 : 645 –6 .
15.
Szabadi E.
Fluvoxamine withdrawal syndrome (letter) . Br J Psychiatry 1992 ; 160 : 283 –4 .
16.
Mallya G
,
White K
,
Gunderson C.
Is there a serotonergic withdrawal syndrome (letter) . Biol Psychiatry 1993 ; 33 : 851 –2 .
17.
Black DW
,
Wesner R
,
Gabel J.
The abrupt discontinuation of fluvoxamine in patients with panic disorder . J Clin Psychiatry 1993 ; 54 : 146 –9 .
18.
Thomas DR
,
Nelson DR
,
Johnson AM
. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor . Psychopharmacology 1987 ; 93 : 193 –200 .
19.
Coccaro EF
. Central serotonin and impulsive aggression . Br J Psychiatry 1989 ; 155 (suppl):52 –62 .
20.
Sanders-Bush E
,
Breeding M
,
Knoth K
,
Tsutsumi M.
Sertraline-induced desensitization of the serotonin 5HT-2 receptor transmembrane signaling system . Psychopharmacology 1989 ; 99 : 64 –9 .